Aurobindo Pharma Limited — Emtricitabine Exporter Profile
Indian Pharmaceutical Exporter · #8 for Emtricitabine · $2.9M export value · DGFT Verified
Aurobindo Pharma Limited is the #8 Indian exporter of Emtricitabine with $2.9M in export value and 58 verified shipments. Aurobindo Pharma Limited holds a 2.6% market share in Emtricitabine exports across 6 countries. The company exports 81 pharmaceutical products worth $1.1B across 18 therapeutic categories.
Aurobindo Pharma Limited — Emtricitabine Export Profile: Buyers & Destinations
Where Does Aurobindo Pharma Limited Export Emtricitabine?
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $2.4M | 50 | 50.0% |
| MALTA | $1.4M | 90 | 28.9% |
| FRANCE | $226.9K | 11 | 4.8% |
| COLOMBIA | $207.3K | 5 | 4.4% |
| SOUTH AFRICA | $200.1K | 5 | 4.2% |
| CANADA | $124.7K | 3 | 2.6% |
| PORTUGAL | $74.9K | 2 | 1.6% |
| MALAYSIA | $63.2K | 7 | 1.3% |
| UNITED STATES OF AMERICA | $50.0K | 1 | 1.1% |
| SPAIN | $48.6K | 2 | 1.0% |
Aurobindo Pharma Limited exports Emtricitabine to 10 countries. The largest destination is UNITED STATES accounting for 50.0% of Aurobindo Pharma Limited's Emtricitabine shipments, followed by MALTA (28.9%) and FRANCE (4.8%). These destinations reflect Aurobindo Pharma Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Emtricitabine from Aurobindo Pharma Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| APL SWIFT SERVICES (MALTA) LTD., | MALTA | $850.4K | 48 |
| AUROLOGISTICS LLC (AUROBINDO PHARMA | UNITED STATES | $750.0K | 15 |
| AUROLOGISTICS LLC | UNITED STATES | $482.5K | 10 |
| AUROLOGISTICS LLC AUROBINDO PHARM | UNITED STATES | $300.0K | 6 |
| QUALLENT PHARMACEUTICALS HEALTH LLC | UNITED STATES | $262.8K | 6 |
| APL SWIFT SERVICES MALTA LTD | MALTA | $243.9K | 16 |
| AUROLOGISTICS LLC(AUROBINDO PHARMA | UNITED STATES | $213.1K | 6 |
| NOVAGEN PHARMA (PTY) LTD, | SOUTH AFRICA | $150.1K | 4 |
| ARROW GENERIQUES | FRANCE | $139.6K | 6 |
| AUROBINDO PHARMA COLOMBIA SAS NIT | COLOMBIA | $131.2K | 3 |
Aurobindo Pharma Limited supplies Emtricitabine to 33 buyers globally. The largest buyer is APL SWIFT SERVICES (MALTA) LTD., (MALTA), followed by AUROLOGISTICS LLC (AUROBINDO PHARMA (UNITED STATES) and AUROLOGISTICS LLC (UNITED STATES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Emtricitabine Export Value and How Much Does Aurobindo Pharma Limited Contribute?
India exported $51.2M worth of Emtricitabine through 2,194 shipments from 141 suppliers to 117 countries, serving 493 buyers globally. Aurobindo Pharma Limited contributes $2.9M to this total, accounting for 2.6% of India's Emtricitabine exports. Aurobindo Pharma Limited ships Emtricitabine to 10 countries through 33 buyers.
What Is the Average Shipment Value for Aurobindo Pharma Limited's Emtricitabine Exports?
Aurobindo Pharma Limited's average Emtricitabine shipment value is $50.0K per consignment, based on 58 shipments totaling $2.9M. The largest destination is UNITED STATES (50.0% of Aurobindo Pharma Limited's Emtricitabine exports).
How Does Aurobindo Pharma Limited Compare to Other Indian Emtricitabine Exporters?
Aurobindo Pharma Limited ranks #8 among 141 Indian Emtricitabine exporters with a 2.6% market share. The top 3 exporters are MACLEODS PHARMACEUTICALS LTD ($14.0M), MYLAN LABORATORIES LIMITED ($13.3M), AUROBINDO PHARMA LTD ($5.9M). Aurobindo Pharma Limited processed 58 shipments to 6 destination countries.
What Emtricitabine Formulations Does Aurobindo Pharma Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| EMTRICITABINE AND TENOFOVIR DISOPROXIL F | $561.5K | 19 |
| EMTRICITABINE 200MG/ TENOFOVIR DISOPROXI | $509.6K | 11 |
| EMTRICITABINE AND TENOFOVIR DISOPROXIL FILMCOATED TABLETS 200MG/245MG 30'S | $155.4K | 7 |
| EMTRICITABINE 200MG/ TENOFOVIR DISOPROXIL FUMARATE 300MG TABLETS 30'S(EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | $150.0K | 3 |
| EMTRICITABINE CAPSULES 200 MG (EMTRICITABINE CAPSULES 200MG) 30'SNOS | $150.0K | 3 |
| EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS 200MG/300MG (24240 X 30S PACKS ) | $132.5K | 3 |
| EMTRICITABINE 200MG/ TENOFOVIR DISOPROXIL FUMARATE 300MG TABLETS (30'S) | $131.2K | 3 |
| EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS 200MG/300MG (15936 X 30S PACK) | $112.8K | 3 |
| EMTRICITABINE 200MG/TENOFOVIR DISOPROXIL | $100.0K | 2 |
| EMTRICITABINE 200MG/ TENOFOVIR DISOPROXIL FUMARATE 300MG TABLETS 30'S (EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | $100.0K | 2 |
Aurobindo Pharma Limited exports 96 distinct Emtricitabine formulations including tablets, capsules, syrups, and combination drugs. The top formulation is EMTRICITABINE AND TENOFOVIR DISOPROXIL F with 19 shipments worth $561.5K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
Regulatory Requirements: Exporting Emtricitabine to Key Markets
What Aurobindo Pharma Limited must comply with to export Emtricitabine to its top destination countries
United States — FDA
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Aurobindo Pharma Limited Compare to Nearest Emtricitabine Exporters?
Exporters ranked immediately above and below #8 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 7 | MACLEODS PHARMACEUTICALS LIMITED | $4.2M | 107 | 19 | $38.8K |
| 6 | HETERO LABS LIMITED | $3.4M | 67 | 26 | $50.0K |
| 8 | AUROBINDO PHARMA LIMITED ★ | $2.9M | 58 | 6 | $50.0K |
| 4 | LUPIN LIMITED | $2.1M | 43 | 4 | $50.0K |
| 5 | CIPLA LIMITED | $2.0M | 40 | 10 | $50.0K |
Aurobindo Pharma Limited ranks #8 among 141 Indian Emtricitabine exporters. Average shipment value of $50.0K compared to the market average of $363.2K. The closest competitors by value are MACLEODS PHARMACEUTICALS LIMITED and HETERO LABS LIMITED.
Which Indian Ports Ship Emtricitabine Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 524 | 23.9% |
| SAHAR AIR | 469 | 21.4% |
| Bombay Air | 166 | 7.6% |
| DELHI AIR | 153 | 7.0% |
| DELHI AIR CARGO ACC (INDEL4) | 141 | 6.4% |
| NHAVA SHEVA SEA (INNSA1) | 60 | 2.7% |
| Bombay Air Cargo | 55 | 2.5% |
| HYDERABAD ACC (INHYD4) | 54 | 2.5% |
About Aurobindo Pharma Limited
Aurobindo Pharma Limited exports 81 products worth $1.1B. Beyond Emtricitabine, top products include Amoxicillin, Potassium, Pantoprazole, Clopidogrel, Rosuvastatin. View the complete Aurobindo Pharma Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Emtricitabine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Emtricitabine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Aurobindo Pharma Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 176 individual customs records matching Aurobindo Pharma Limited exporting Emtricitabine, covering 96 formulations to 10 countries via 33 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 117+ countries, 493+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Emtricitabine Export Data from Aurobindo Pharma Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Aurobindo Pharma Limited's Emtricitabine exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Aurobindo Pharma Limited
Full Company Profile →
81 products · $1.1B total trade · 18 categories
Emtricitabine Stats
Company Overview
Top Products by Aurobindo Pharma Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Aurobindo Pharma Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Emtricitabine. For current shipment-level data, contact TransData Nexus.